119 related articles for article (PubMed ID: 11023613)
1. Human TP53 from the malignant glioma-derived cell lines M059J and M059K has a cancer-associated mutation in exon 8.
Anderson CW; Allalunis-Turner MJ
Radiat Res; 2000 Oct; 154(4):473-6. PubMed ID: 11023613
[TBL] [Abstract][Full Text] [Related]
2. Characterisation of molecular alterations in microdissected archival gliomas.
Walker C; Joyce KA; Thompson-Hehir J; Davies MP; Gibbs FE; Halliwell N; Lloyd BH; Machell Y; Roebuck MM; Salisbury J; Sibson DR; Du Plessis D; Broome J; Rossi ML
Acta Neuropathol; 2001 Apr; 101(4):321-33. PubMed ID: 11355303
[TBL] [Abstract][Full Text] [Related]
3. Molecular pathology of primary and metastatic ductal pancreatic lesions: analyses of mutations and expression of the p53, mdm-2, and p21/WAF-1 genes in sporadic and familial lesions.
Ruggeri BA; Huang L; Berger D; Chang H; Klein-Szanto AJ; Goodrow T; Wood M; Obara T; Heath CW; Lynch H
Cancer; 1997 Feb; 79(4):700-16. PubMed ID: 9024708
[TBL] [Abstract][Full Text] [Related]
4. Frameshift mutation in PRKDC, the gene for DNA-PKcs, in the DNA repair-defective, human, glioma-derived cell line M059J.
Anderson CW; Dunn JJ; Freimuth PI; Galloway AM; Allalunis-Turner MJ
Radiat Res; 2001 Jul; 156(1):2-9. PubMed ID: 11418067
[TBL] [Abstract][Full Text] [Related]
5. Introduction of wild-type p53 enhances thrombospondin-1 expression in human glioma cells.
Harada H; Nakagawa K; Saito M; Kohno S; Nagato S; Furukawa K; Kumon Y; Hamada K; Ohnishi T
Cancer Lett; 2003 Feb; 191(1):109-19. PubMed ID: 12609716
[TBL] [Abstract][Full Text] [Related]
6. Differential gene expression in human glioma cells: correlation with presence or absence of DNA-dependent protein kinase.
Ai R; Sandoval A; Labhart P
Gene Expr; 2003; 11(1):35-45. PubMed ID: 12691524
[TBL] [Abstract][Full Text] [Related]
7. p53 protein accumulation and gene mutations in human glioma cell lines.
Anker L; Ohgaki H; Ludeke BI; Herrmann HD; Kleihues P; Westphal M
Int J Cancer; 1993 Dec; 55(6):982-7. PubMed ID: 8253536
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of the chemosensitivity of head and neck cancer cells based on the diverse function of mutated-p53.
Shinagawa Y; Kawamata H; Omotehara F; Nakashiro K; Hoque MO; Furihata T; Horiuchi H; Imai Y; Fujimori T; Fujibayashi T
Int J Oncol; 2003 Feb; 22(2):383-9. PubMed ID: 12527938
[TBL] [Abstract][Full Text] [Related]
9. Mutation profile of the p53, fhit, p16INK4a/p19ARF and H-ras genes in Indian breast carcinomas.
Kannan K; Krishnamurthy J; Feng J; Nakajima T; Tsuchida N; Shanmugam G
Int J Oncol; 2000 Nov; 17(5):1031-5. PubMed ID: 11029509
[TBL] [Abstract][Full Text] [Related]
10. Evidence of gene deletion of p21 (WAF1/CIP1), a cyclin-dependent protein kinase inhibitor, in thyroid carcinomas.
Shi Y; Zou M; Farid NR; al-Sedairy ST
Br J Cancer; 1996 Nov; 74(9):1336-41. PubMed ID: 8912526
[TBL] [Abstract][Full Text] [Related]
11. Initiation of human astrocytoma by clonal evolution of cells with progressive loss of p53 functions in a patient with a 283H TP53 germ-line mutation: evidence for a precursor lesion.
Fulci G; Ishii N; Maurici D; Gernert KM; Hainaut P; Kaur B; Van Meir EG
Cancer Res; 2002 May; 62(10):2897-905. PubMed ID: 12019170
[TBL] [Abstract][Full Text] [Related]
12. Expression of cell cycle regulator genes in KB, a human squamous cell carcinoma cell line, after irradiation.
Uno M; Otsuki T; Hiratsuka J; Yoden E; Aihara T; Harada T; Imajo Y
Int J Oncol; 2000 Nov; 17(5):947-54. PubMed ID: 11029497
[TBL] [Abstract][Full Text] [Related]
13. [Sequence analysis of N--ras and p53 gene mutation in the human lung adenocarcinoma cell lines].
Zhang WM; Yu H; Li WD
Zhonghua Bing Li Xue Za Zhi; 1994 Dec; 23(6):334-7. PubMed ID: 7720110
[TBL] [Abstract][Full Text] [Related]
14. Induction of differentiation by wild-type p53 gene in a human glioma cell line.
Kokunai T; Kawamura A; Tamaki N
J Neurooncol; 1997 Apr; 32(2):125-33. PubMed ID: 9120541
[TBL] [Abstract][Full Text] [Related]
15. Altered structure and expression of the p53 gene in human neuroepithelial tumors.
Tabuchi K; Fukuyama K; Mineta T; Oh-Uchida M; Hori K
Neurol Med Chir (Tokyo); 1992 Sep; 32(10):725-32. PubMed ID: 1280773
[TBL] [Abstract][Full Text] [Related]
16. Expression of p16INK4a/p16alpha and p19ARF/p16beta is frequently altered in non-small cell lung cancer and correlates with p53 overexpression.
Vonlanthen S; Heighway J; Tschan MP; Borner MM; Altermatt HJ; Kappeler A; Tobler A; Fey MF; Thatcher N; Yarbrough WG; Betticher DC
Oncogene; 1998 Nov; 17(21):2779-85. PubMed ID: 9840942
[TBL] [Abstract][Full Text] [Related]
17. Identification and chromosomal assignment of two heterozygous mutations in the Trp53 gene in L5178Y/Tk(+/-)-3.7.2C mouse lymphoma cells.
Clark LS; Hart DW; Vojta PJ; Harrington-Brock K; Barrett JC; Moore MM; Tindall KR
Mutagenesis; 1998 Sep; 13(5):427-34. PubMed ID: 9800187
[TBL] [Abstract][Full Text] [Related]
18. Mutations of p53 gene in gastric carcinoma in Taiwan.
Wang JY; Lin SR; Hsieh JS; Hsu CH; Huang YS; Huang TJ
Anticancer Res; 2001; 21(1B):513-20. PubMed ID: 11299797
[TBL] [Abstract][Full Text] [Related]
19. TP53 gene mutations, nuclear p53 accumulation, expression of Waf/p21, Bcl-2, and CD95 (APO-1/Fas) proteins are not prognostic factors in de novo glioblastoma multiforme.
Kraus JA; Wenghoefer M; Glesmann N; Mohr S; Beck M; Schmidt MC; Schröder R; Berweiler U; Roggendorf W; Diete S; Dietzmann K; Heuser K; Müller B; Fimmers R; von Deimling A; Schlegel U
J Neurooncol; 2001 May; 52(3):263-72. PubMed ID: 11519857
[TBL] [Abstract][Full Text] [Related]
20. Characterization of p53 and p21 functional interactions in glioma cells en route to apoptosis.
Gomez-Manzano C; Fueyo J; Kyritsis AP; McDonnell TJ; Steck PA; Levin VA; Yung WK
J Natl Cancer Inst; 1997 Jul; 89(14):1036-44. PubMed ID: 9230885
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
